FOURTH QUARTER 2021
Earnings conference call
February 9, 2022
KAREN S. LYNCH
President
and Chief Executive Officer
SHAWN M. GUERTIN
Executive Vice President and Chief Financial Officer
Cautionary statement
concerning forward-looking statements
2 ©2022 CVS Health and/or one of its affiliates.
This presentation includes forward-looking statements. The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-lookingstatements made by or on behalf of CVS Health Corporation. By their nature, all forward-lookingstatements are not guarantees of future performance or results and are subject to risks and uncertainties that are difficult to predict and/or quantify. Actual results may differ materially from those contemplated by the forward-lookingstatements due to the risks and uncertainties related to the COVID-19pandemic, including the potential emergence of additional variants, vaccine and testing protocols, government testing initiatives, the geographies impacted by and the severity and duration of the pandemic, the pandemic's impact on the U.S. and global economies and consumer behavior and health care utilization patterns, and the timing, scope and impact of stimulus legislation and other federal, state and local governmental responses to the pandemic, as well as the risks and uncertainties described in our Securities and Exchange Commission filings, including those set forth in the Risk Factors section and under the heading "Cautionary Statement Concerning Forward-LookingStatements" in our most recent Annual Report on Form 10-Kand our recent Current Reports on Form 8-K.
This presentation includes non-GAAP financial measures that we use to describe our company's performance. In accordance with SEC regulations, you can find the definitions of these non-GAAP measures, as well as reconciliations to the most directly comparable GAAP measures, on the Investor Relations portion of our website.
Link to our non-GAAP Reconciliations
Financial highlights
FY 2021 Adjusted EPS of $8.40 exceeded expectations; Maintaining FY 2022 guidance for Adjusted Operating Income and Adjusted EPS
$1.98 | 10.6% | $4.0 billion | ||
Q4 adjusted EPS | Q4 adjusted | Q4 cash flow from operations | ||
Reflects adjusted operating | revenue growth | Committed to disciplined | ||
income growth across all | Reflects growth across | capital allocation priorities | ||
businesses | all businesses |
Evidence
our strategy and execution is delivering value across the health care system for
our customers, our communities, our colleagues and our shareholders
FY 2022 guidance
Total company adjusted operating income
$16.7B - $17.1B
Total company adjusted EPS
$8.10 - $8.30
Cash flow from operations
$12.0 - $13.0B
strong
balance sheet
Paid down $2.3B in debt in Q4 and net $8.8B in Full-Year
3 ©2022 CVS Health and/or one of its affiliates.
Unifying our business around the consumer health experience and scale new sources of value
4 ©2022 CVS Health and/or one of its affiliates.
1
2
3
4
5
Advance all-payer primary care delivery capabilities
Optimize retail portfolio to serve as community health destinations
Diversify our growth portfolio with new health services
Drive digital-first,technology-forward approach
Enhance omnichannel health experiences
CVS Health continues to lead the nation's COVID-19response
>32M tests administered in 2021
>59M vaccines administered in 2021
~37M new customers through COVID-19 testing and vaccine services since inception
~14% of customers new to CVS Health through COVID-19 testing services chose to fill new prescriptions or receive their vaccinations at CVS Health*
*New COVID-19 testing patients defined as those who have had 12 months elapse since their COVID-19 test.
5 ©2022 CVS Health and/or one of its affiliates.
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
CVS Health Corporation published this content on 09 February 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 09 February 2022 12:08:03 UTC.